Searched for
BRITISH DRUGMAKER NEWS
GSK picks Burberry's Julie Brown as first female CFOBrown, also 60, will join GSK in April and take up the job in May. She has previously done stints in the health and pharmaceuticals industr...- Wall Street closes higher with Nasdaq boosted by tech rallyThe Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the N...
- European stocks scale all-time highs with miners in the leadThe pan-European STOXX 600 rose 0.5 per cent by 0720 GMT, adding to gains made earlier this week when the index erased all of its pandemic-...
- EU audits Serum Institute as AstraZeneca looks to boost supplies to the bloc: SourceSII, the world's largest vaccine manufacturer, is producing the AstraZeneca vaccine, developed with Oxford University, for dozens of poor a...
- London stocks gain as AstraZeneca, Indivior jump; weaker pound supportsThe blue-chip FTSE 100 index climbed 0.5%, with healthcare stocks leading the gains, while the domestically focussed mid-cap index added 0....
- UK puts millions more under tight restrictions as cases soarIn England's Tier 4, most people are advised to stay home, barred from mixing with the members of other households either indoors or out, n...
- India likely to approve AstraZeneca vaccine by next week, could become 1st country to do soIndia, the world's biggest vaccine-making country, wants to start inoculating its citizens next month and is also considering emergency use...
- AstraZeneca hitches ride with Russia's Sputnik in vaccine raceTrials will start by the end of the year and Russia wants to jointly produce the new vaccine if it is proven to be effective, said the RDIF...
- Oil prices rise on Covid-19 vaccine newsSentiment was also bolstered by expectations that the Organization of the Petroleum Exporting Countries (OPEC), Russia and other producers,...
- AstraZeneca/Oxford say Covid vaccine shows 70% efficacy, can be 90% effective"This vaccine's efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this pub...
- Wall Street closes broadly higher on deal news, vaccine hopesDrugmaker AstraZeneca resumed its British clinical trials of its COVID-19 vaccine, one of the most advanced in development.
- Wall Street closes broadly higher on deal news, vaccine hopesAlso, Pfizer Inc rose 2.6% after the drugmaker and German biotech firm BioNTech SE proposed to expand their Phase 3 pivotal COVID-19 vaccin...
- Vaccine hopes, global M&A boost European stocksThe pan-European STOXX 600 index rose 0.7% by 0711 GMT on Monday, hitting its highest level in over a week, while the German and French ind...
- European shares open higher ahead of service-sector dataData from the euro zone is expected to show service-sector growth for a second straight month.
- Chinese police charge British former GSK China head with briberyMark Reilly and two Chinese executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry.
- Pfizer boss enters lion's den of UK politics to sell AstraZeneca dealIn Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.
- AstraZeneca to close its Bangalore R&D unitThe decision to shut the R&D centre is part of an ongoing global restructuring exercise, said the company that employs over 1,200 people in...
- Piramal denies takeover bid by GlaxoGlaxoSmithKline is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for around $1.5 billion.
- Glaxo in talks for Pirmal HealthcareBritish pharma major GlaxoSmithKline Plc is in early stages of discussions to acquire Indian generic drug maker Piramal Healthcare for arou...
- Ranbaxy, GlaxoSmithKline settle Valtrex disputeRanbaxy reaches an agreement with GlaxoSmithKline to settle their dispute over a US patent covering Valtrex.
Load More
